Search
LY295427
Synthetic sterol.
Mechanism of action:
1) reduces plasma cholesterol by increasing expression of LDL receptor
2) reverses oxysterol-induced suppression of sterol regulatory element binding protein (SREBP) processing
Interactions
drug adverse effects of anti-hyperlipidemic agents
Related
low-density lipoprotein receptor; LDL receptor; apoB/E receptor (LDLR)
sterol regulatory element binding protein (SREBP)
General
anti-hyperlipidemic agent
sterol
References
- Janowskii et al,
The hypocholesterolemic agent LY295427 reverses suppression of
sterol regulatory element-binding protein processing mediated
by oxysterols.
J Biol Chem 276:45408, 2001
PMID: 11577112